首页> 外国专利> Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness

Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness

机译:用于减少患有已确诊或未确诊的呼吸系统疾病患者服用阿片类镇痛药的风险的方法和组合物

摘要

The present invention relates to methods for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed with respiratory illness by administering an analgesic composition comprising a sub-analgesic dosage of a μ-opioid agonist selected from the group consisting of morphine, fentanyl, sufentanil, alfentanil, oxymorphone and hydromorphone, or a pharmaceutically acceptable salt thereof, and a sub-analgesic dosage of oxycodone which is a κ2-opioid agonist or a pharmaceutically acceptable salt thereof.
机译:本发明涉及通过施用包含亚镇痛剂量的选自阿片吗啡的μ阿片类激动剂的镇痛组合物来降低在诊断或未诊断为呼吸系统疾病的患者中与给予阿片类镇痛药有关的风险的方法。芬太尼,舒芬太尼,阿芬太尼,羟吗啡酮和氢吗啡酮或其药学上可接受的盐,以及作为κ2 -Sub阿片类激动剂的羟考酮的亚镇痛剂量或其药学上可接受的盐。

著录项

  • 公开/公告号US2005053659A1

    专利类型

  • 公开/公告日2005-03-10

    原文格式PDF

  • 申请/专利权人 GARY W. PACE;MAREE T. SMITH;

    申请/专利号US20030661458

  • 发明设计人 GARY W. PACE;MAREE T. SMITH;

    申请日2003-09-10

  • 分类号A61K31/485;A61K31/445;A61K9/22;

  • 国家 US

  • 入库时间 2022-08-21 22:21:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号